Amanote Research
Register
Sign In
P1.04-12 Mass Spectrometry-Based Serum Proteomic Signature as a Potential Biomarker for Survival in NSCLC Patients With Immunotherapy
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.727
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
Y. Chae
W.B. Kim
N. Simon
K. Rhee
J. Song
A. Cho
M. Oh
W. Iams
A. Davis
J. Anker
L.C. Park
Publisher
Elsevier BV